We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$188B
AUM Growth
+$6.54B
(+3.6%)
Cap. Flow
-$6.74B
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
4,804
New
439
Increased
1,801
Reduced
1,889
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$387M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$183M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$144M |
| 4 |
Zai Lab
ZLAB
|
+$123M |
| 5 |
Halliburton
HAL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$832M |
| 2 |
Alibaba
BABA
|
+$374M |
| 3 |
Microsoft
MSFT
|
+$321M |
| 4 |
Apple
AAPL
|
+$273M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 8.3% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Amneal Pharmaceuticals
AMRX
$5.9B
| $270K | ﹤0.01% |
56,231
-2,313
| -4% | -$11.5K |
|
|
MLNK
4027
DELISTED
MeridianLink
MLNK
| $270K | ﹤0.01% |
+12,553
| New | +$285K |
|
4028
Oric Pharmaceuticals
ORIC
$1.39B
| $270K | ﹤0.01% |
18,391
+2,224
| +14% | +$34.7K |
|
|
TRUE
4029
DELISTED
TrueCar
TRUE
| $270K | ﹤0.01% |
79,625
-4,856
| -6% | -$18.5K |
|
4030
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $270K | ﹤0.01% |
+2,412
| New | +$262K |
|
|
TIXT
4031
DELISTED
TELUS International
TIXT
| $269K | ﹤0.01% |
+8,142
| New | +$284K |
|
4032
Future Fuel
FF
$216M
| $268K | ﹤0.01% |
35,099
-789
| -2% | -$6.12K |
|
4033
VanEck Low Carbon Energy ETF
SMOG
$133M
| $267K | ﹤0.01% |
1,666
| – | – |
|
4034
International Money Express
IMXI
$370M
| $265K | ﹤0.01% |
16,600
-202
| -1% | -$3.27K |
|
|
ALLK
4035
DELISTED
Allakos
ALLK
| $262K | ﹤0.01% |
26,887
-132
| -0.5% | -$10.8K |
|
|
EWCZ
4036
DELISTED
European Wax Center
EWCZ
| $262K | ﹤0.01% |
+8,662
| New | +$246K |
|
4037
Five Point Holdings
FPH
$379M
| $262K | ﹤0.01% |
39,991
-7,681
| -16% | -$51.9K |
|
4038
Veru
VERU
$38M
| $262K | ﹤0.01% |
4,466
+826
| +23% | +$63.2K |
|
4039
Star Bulk Carriers
SBLK
$3.15B
| $260K | ﹤0.01% |
+11,457
| New | +$241K |
|
4040
Oramed Pharmaceuticals
ORMP
$183M
| $259K | ﹤0.01% |
+18,123
| New | +$379K |
|
|
RUBY
4041
DELISTED
Rubius Therapeutics, Inc
RUBY
| $259K | ﹤0.01% |
26,874
+1,091
| +4% | +$15.1K |
|
4042
Capital City Bank Group
CCBG
$902M
| $258K | ﹤0.01% |
9,808
+926
| +10% | +$25K |
|
4043
Joby Aviation
JOBY
$7.84B
| $258K | ﹤0.01% |
35,461
-12,539
| -26% | -$104K |
|
|
AIFU
4044
AIFU Inc
AIFU
$220M
| $257K | ﹤0.01% |
88
-2,664
| -97% | -$12.8M |
|
4045
Tango Therapeutics
TNGX
$4.78B
| $256K | ﹤0.01% |
+23,422
| New | +$282K |
|
4046
dLocal
DLO
$4.5B
| $255K | ﹤0.01% |
+7,135
| New | +$308K |
|
4047
Humacyte
HUMA
$192M
| $255K | ﹤0.01% |
+35,148
| New | +$348K |
|
4048
ProShares Ultra Communication Services
LTL
$6.63M
| $255K | ﹤0.01% |
18,536
-23,232
| -56% | -$289K |
|
|
NVTA
4049
CALL
DELISTED
Invitae Corporation
NVTA
| $255K | ﹤0.01% |
16,700
| – | – |
|
4050
Oportun Financial
OPRT
$276M
| $254K | ﹤0.01% |
+12,603
| New | +$295K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2021 Portfolio in Review
As of Q4 2021, Credit Suisse held 4,804 positions worth $188B, up 3.6% from $182B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $6.74B in Q4 2021, closing 333 positions and reducing 1,889 holdings. Its most notable exit was Kansas City Southern, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Bank of America Series L worth $48.1M.
- Credit Suisse's largest Q4 2021 buy was Bank of America Series L: 33,252 shares worth $48.1M.
- Credit Suisse added most to Linde in Q4 2021, an estimated $387M increase.
- Credit Suisse's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $832M.
- Credit Suisse fully exited Kansas City Southern in Q4 2021, selling an estimated $126M.
- Credit Suisse's ten largest holdings make up 17% of its $188B portfolio in Q4 2021.
- Credit Suisse opened 439 new positions and closed 333 in Q4 2021.
- Credit Suisse's portfolio value rose 3.6% quarter-over-quarter to $188B.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.